ArticleJapanese journal of clinical oncology2017

Evaluation of renal function change during first-line tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma.

Hiroki Ishihara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.